review Open AccessTop 1% cited
Early Detection, Curative Treatment, and Survival Rates for Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis: A Meta-analysis
PLoS Medicine · 2014 · Vol. 11(4) · pp. e1001624–e1001624
Amit G. Singal✉(The University of Texas Southwestern Medical Center)Anjana Pillai(Emory University)Jasmin A. Tiro(The University of Texas Southwestern Medical Center)
Abstract
HCC surveillance is associated with significant improvements in early tumor detection, receipt of curative therapy, and overall survival in patients with cirrhosis. Please see later in the article for the Editors' Summary.
Hepatocellular Carcinoma Treatment and PrognosisLiver Disease Diagnosis and TreatmentHepatitis B Virus StudiesMedicineHepatocellular carcinomaOdds ratioInternal medicineCirrhosisMeta-analysisPopulationRandomized controlled trialStage (stratigraphy)Environmental health
MeSH terms
Carcinoma, HepatocellularHumansLiver CirrhosisLiver NeoplasmsPopulation SurveillanceSurvival RateEarly Detection of Cancer
Funding
- University of Texas Southwestern Medical Center
- National Institutes of Health
- National Center for Advancing Translational Sciences
Citations
806
FWCI
23.70
field-weighted impact
References
91
Percentile
100%
vs. same field & year
Citations per year
Cited by
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
Hepatology · 2018 · 4,515 citations
AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma
Hepatology · 2023 · 1,480 citations
AASLD guidelines for the treatment of hepatocellular carcinoma
Hepatology · 2017 · 4,115 citations
Epidemiology and surveillance for hepatocellular carcinoma: New trends
Journal of Hepatology · 2020 · 1,083 citations
References
Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma
Gastroenterology · 2012 · 3,378 citations
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Annals of Internal Medicine · 2009 · 37,606 citations
Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference
Journal of Hepatology · 2001 · 4,075 citations
Measuring inconsistency in meta-analyses
BMJ · 2003 · 61,700 citations
Quantifying heterogeneity in a meta‐analysis
Statistics in Medicine · 2002 · 36,106 citations
Hepatocellular carcinoma in cirrhosis: Incidence and risk factors
Gastroenterology · 2004 · 2,570 citations
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
BMJ · 2009 · 82,871 citations
Management of Hepatocellular Carcinoma: An Update Δσ
Hepatology · 2011 · 8,095 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.